Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.15 +0.07 (+1.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Vanda Pharmaceuticals (VNDA) Depreciation & Amortization - Total (2017 - 2026)

Updated

Vanda Pharmaceuticals' Depreciation & Amortization - Total came in at $267,000 for Q2 2026, unchanged from $267,000 a year earlier and down 2.2% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Depreciation & Amortization - Total (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vanda Pharmaceuticals reported Depreciation & Amortization - Total of $1.15 million, up 17.3% year-over-year; for FY2025, it was $1.1 million, up 22.6% from FY2024.

  • Depreciation & Amortization - Total carries a five-year compound annual growth rate of -4.7% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization - Total was $900,000 in FY2024 (-2.2%), $920,000 in FY2023 (-24.4%), $1.22 million in FY2022 (-13.1%) and $1.4 million in FY2021 (unchanged).
  • The five-year range for quarterly Depreciation & Amortization - Total is $200,000 (Q3 2023) to $374,000 (Q4 2021).
  • Year-over-year, Depreciation & Amortization - Total increased in seven of the last eight quarters, with growth averaging 18.1%.
  • The fastest year-over-year change in Depreciation & Amortization - Total over five years came in Q3 2025 (growth of 39.4%), and the weakest in Q3 2023 (a decline of 33.1%).
  • Business Quant data shows VNDA's Depreciation & Amortization - Total at $273,000 (Q1 2026), $304,000 (Q4 2025) and $301,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vanda Pharmaceuticals 246.71 Mn -529.97 Mn 65.66 Mn 243,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 243,000.00
Jun 30, 2026 267,000.00
Mar 31, 2026 273,000.00
Dec 31, 2025 304,000.00
Sep 30, 2025 301,000.00
Jun 30, 2025 267,000.00
Mar 31, 2025 231,000.00
Dec 31, 2024 262,000.00
Sep 30, 2024 216,000.00
Jun 30, 2024 216,000.00
Mar 31, 2024 206,000.00
Dec 31, 2023 205,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 224,000.00
Mar 31, 2023 291,000.00
Dec 31, 2022 284,000.00
Sep 30, 2022 299,000.00
Jun 30, 2022 311,000.00
Mar 31, 2022 323,000.00
Dec 31, 2021 374,000.00
API Access

Vanda Pharmaceuticals Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=VNDA&period=max&api_key=YOUR_API_KEY